Challenges in translating evidence to practice: The provision of intrauterine contraception

Obstetrics and Gynecology

Volumn 111, Issue 6, 2008, Pages 1359-1369

  Harper, Cynthia C ^a,b   Blum, Maya ^a   De Bocanegra, Heike Thiel ^a   Darney, Philip D ^a   Speidel, J Joseph ^a   Policar, Michael ^a   Drey, Eleanor A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Box 0744 UCSF ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LEVONORGESTREL;

ABORTION; ADULT; ARTICLE; BLEEDING; CLINICAL ASSESSMENT; CONTRACEPTION; EVIDENCE BASED MEDICINE; FAMILY PLANNING; FEMALE; HEALTH CARE PERSONNEL; HEALTH PROGRAM; HEALTH SURVEY; HUMAN; INTRAUTERINE CONTRACEPTIVE DEVICE; KNOWLEDGE; LOWEST INCOME GROUP; MAJOR CLINICAL STUDY; MALE; MARITAL THERAPY; MEDICAL PRACTICE; MEDICAL SPECIALIST; NULLIPARA; NURSE; PHYSICIAN; PHYSICIAN ASSISTANT; PRIORITY JOURNAL; RESIDENCY EDUCATION; UNITED STATES; AGE; ATTITUDE TO HEALTH; COUNSELING; INDUCED ABORTION; INFORMATION PROCESSING; MIDDLE AGED; NURSE PRACTITIONER; PARITY; PREGNANCY; STATISTICAL MODEL;

ABORTION, INDUCED; AGE FACTORS; CALIFORNIA; COUNSELING; DATA COLLECTION; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEALTH PERSONNEL; HUMANS; INTRAUTERINE DEVICES; LOGISTIC MODELS; MALE; MIDDLE AGED; NURSE PRACTITIONERS; PARITY; PHYSICIAN ASSISTANTS; PHYSICIANS; PREGNANCY;

EID: 47749153819     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1097/AOG.0b013e318173fd83     Document Type: Article

References (38)

1. Finer LB, Henshaw SK. Disparities in rates of unintended pregnancy in the United States, 1994 and 2001. Perspect Sex Reprod Health 2006;38:90-6.
2. Trussell J. The essentials of contraception: efficacy, safety, and personal considerations. In: Hatcher RA, Trussell J, Nelson AL, Cates C, Guest F, Kowal D, eds. Contraceptive Technology. 18 ed. New York (NY): Ardent Media; 2004:221-52.
3. Clinical management guidelines for obstetrician-gynecologists. Intrauterine device. ACOG practice bulletin No. 59. American College of Obstetricians and Gynecologists. Obstet Gynecol 2005;105:223-32.
4. United Nations Department of Economic and Social Affairs Population Division. World contraceptive use 2005. Available at: http://www.un.org/esa/ population/publications/contraceptive 2005/2005-World-Contraceptive-files/ WallChart-WCU2005. pdf. Retrieved June 19, 2007.
5. Sivin I. IUDs and ectopic pregnancy [French]. Contracept Fertil Sex (Paris) 1983 Dec;11:1287-94.
6. Grimes D. Intrauterine device and upper-genital-tract infection. Lancet 2000;356:1013-9.
7. Kimble-Haas SL. The intrauterine device: dispelling the myths. Nurse Pract 1998;23:58, 63-9, 73.
8. Darney PD. Time to pardon the IUD? N Engl J Med 2001; 345:608-10.
9. Stanwood NL, Garrett JM, Konrad TR. Obstetrician-gynecologists and the intrauterine device: a survey of attitudes and practice. Obstet Gynecol 2002;99:275-80.
10. Lee NC, Rubin GL, Ory HW, Burkman RT. Type of intra-uterine device and the risk of pelvic inflammatory disease. Obstet Gynecol 1983;62:1-6.
11. Shelton JD. Risk of clinical pelvic inflammatory disease attributable to an intrauterine device. Lancet 2001;357:443.
12. Hubacher D, Lara-Ricalde R, Taylor DJ, Guerra-Infante F, Guzman-Rodriguez R. Use of copper intrauterine devices and the risk of tubal infertility among nulligravid women. N Engl J Med 2001; 345:561-7.
13. Postlethwaite D, Shaber R, Mancuso V, Flores J, Armstrong MA. Intrauterine contraception: evaluation of clinician practice patterns in Kaiser Permanente Northern California. Contraception 2007;75:177-84.
14. UCSF Bixby Center for Reproductive Health Research & Policy. Family PACT Program Report Fiscal Year 03/04. San Francisco, CA, 2005. Available at http://www.familypract.org/ -resources/documents/0203.pdf. Retrieved April 8, 2008.
15. World Health Organization. Medical eligibility criteria. Geneva: WHO; 2004.
16. Prager S, Darney PD. The levonorgestrel intrauterine system in nulliparous women. Contraception 2007;75:S12-5.
17. Suhonen S, Haukkamaa M, Jakobsson T, Rauramo I. Clinical performance of a levonorgestrel-releasing intrauterine system and oral contraceptives in young nulliparous women: a comparative study. Contraception 2004;69:407-12.
18. Ogburn J, Espey E, Stonehocker J. Barriers to intrauterine device insertion in postpartum women. Contraception 72; 2005:426-9.
19. Grimes D, Schulz K, Van Vliet H, Stanwood N, Lopez L. Immediate post-partum insertion if intrauterine devices. Cochrane Database of Systematic Reviews 2001; Art. No.: CD003036. DOI: 10.1002/14651858.CD003036.
20. Celen S, Möröy P, Sucak A, Aktulay A, Danisman N. Clinical outcomes of early postplacental insertion of intrauterine contraceptive devices. Contraception 2004;69:279-82.
21. Jones R, Singh S, Finer L, Forhwirth L. Repeat abortion in the United States: Guttmacher Institute; 2006. Available at http:// www.guttmacher.org/ pubs/2006/11/21/or29.pdf. Retrieved April 4, 2008.
22. Grimes D, Lopez L, Schulz K, Stanwood N. Immediate postabortal insertion of intrauterine devices. Cochrane Database of Systematic Reviews 2004; Art. No.: CD001777. DOI: 10.1002/14651858.CD01777.pub2.
23. Li CF, Lee SS, Pun TC. A pilot study on the acceptability of levonorgestrel-releasing intrauterine device by young, single, nulliparous Chinese females following surgical abortion. Contraception 2004;69:247-50.
24. Richardson BA, Morrison CS, Sekadde-Kigondu C, Sinei SK, Overbaugh J, Panteleeff DD, et al. Effect of intrauterine device use on cervical shedding in HIV-1 DNA. AIDS 1999;13:2091-7.
25. Morrison CS, Sekadde-Kigondu C, Sinei SK, Weiner DH, Kwok C, Dokonya D. Is the intrauterine device appropriate contraception for HIV-1-infected women? Br J Obstet Gynecol 2001;108:784-90.
26. Heikinheimo O, Lehtovirta P, Suni J, Paavonen J. The levonorg-estrel- releasing intrauterine system (LNG-IUS) in HIV-infected women-effects on bleeding patterns, ovarian function and genital shedding of HIV. Hum Reprod 2006;21:2857-61.
27. Lehtovirta P, Paavonen J, Heikinheimo O. Experience with the levonorgestrel-releasing intrauterine system among HIV-in-fected women. Contraception 2007;75:37-9.
28. Gaffikin L, Phiri A, McGrath J, Zinanga A, Blumenthal PD. Provider attitudes toward IUC provision in Zimbabwe: perception of HIV risk and training implications. Adv Contracept 1998;14:27-39.
29. Mishell DR Sulak PJ. The IUD: dispelling the myths and assessing the potential. Dialogues Contracept 1997;5:1-4.
30. Cheng D. The intrauterine device: still misunderstood after all these years. South Med J 2000;93:859-64.
31. Kooiker CH, Scutchfield FD. Barriers to prescribing the Copper T 380A intrauterine device by physicians. West J Med 1990;153:279-82.
32. Espey E, Ogburn T, Espey D, Etsitty V. IUD-related knowledge, attitudes and practices among Navajo Area Indian Health Service providers. Perspect Sex Reprod Health 2003; 35:169-73.
33. Rivera R, Best K. Current opinion: consensus statement on intrauterine contraception. Contraception 2002;65: 385-8.
34. Farr G, Rivera R, Amatya R. Non-physician insertion of IUDs: clinical outcomes among TCu380A insertions in three developing-country clinics. Adv Contracept 1998;14: 45-57.
35. Freeman S. Nondaily hormonal contraception: considerations in contraceptive choice and patient counseling. J Am Acad Nurse Pract 2004;16:226-38.
36. Wesson J, Gmach R, Gazi R, Ashraf A, Méndez JF, Olenja J, et al. Provider views on the acceptability of an IUD checklist screening tool. Contraception 2006;74:382-8.
37. Hubacher D, Vilchez R, Gmach R, Jarquin C, Medrano J, Gadea A, et al. The impact of clinician education on IUD uptake, knowledge and attitudes: results of a randomized trial. Contraception 2006;73:628-33.
38. Chiou CF, Trussell J, Reyes E, Knight K, Wallace J, Udani J, et al. Economic analysis of contraceptives for women. Contraception 2003;68:3-10.